Loss of efficacy of secukinumab for psoriasis at 24 to 32 weeks.

Autor: Huang YYM; Department of Dermatology, Baylor College of Medicine, Houston, Texas. Electronic address: ymhuang@bcm.edu., Ruth JS; Department of Dermatology, Baylor College of Medicine, Houston, Texas., Hsu S; Department of Dermatology, Baylor College of Medicine, Houston, Texas.
Jazyk: angličtina
Zdroj: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2016 Oct; Vol. 75 (4), pp. e169.
DOI: 10.1016/j.jaad.2016.05.049
Databáze: MEDLINE